Follow the people · Insider
Pravin Dugel
Pravin Dugel files insider transactions with the SEC as a director and officer of Ocular Therapeutix (OCUL). We hold 4 disclosed purchases and sales filed since 22 June 2018, 1 of them in the last 90 days.
- Files forOCUL
- Disclosed buys and sells4 in all, 1 in the last 90 days
- Last disclosure26 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 February 2024 — 25 August 2026Director and Officer · Ocular Therapeutix (OCUL)33 Form 4 lines · source: SEC Form 4
- Filed 18 December 2020 — 11 July 2023President · IVERIC bio (ISEE)42 Form 4 lines · source: SEC Form 4
- Filed 20 June 2018 — 30 June 2021Director · Aerpio Pharmaceuticals (ARPO)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
82 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 21,649 shares of Ocular TherapeutixSEC Form 426 August 2026Common Stock · traded 24 August 2026 · filed 26 August 2026
- gave away 50,092 shares of Ocular TherapeutixSEC Form 426 August 2026Common Stock · traded 25 August 2026 · filed 26 August 2026
- gave away 50,092 shares of Ocular TherapeutixSEC Form 426 August 2026Common Stock · traded 25 August 2026 · filed 26 August 2026
- gave away 50,092 shares of Ocular TherapeutixSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- gave away 50,092 shares of Ocular TherapeutixSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 21,156 shares of Ocular TherapeutixSEC Form 428 May 2026Common Stock · traded 26 May 2026 · filed 28 May 2026
- gave away 394,696 shares of Ocular TherapeutixSEC Form 428 May 2026Common Stock · traded 28 May 2026 · filed 28 May 2026
- gave away 394,696 shares of Ocular TherapeutixSEC Form 428 May 2026Common Stock · traded 28 May 2026 · filed 28 May 2026
- gave away 394,696 shares of Ocular TherapeutixSEC Form 413 April 2026Common Stock · traded 9 April 2026 · filed 13 April 2026
- gave away 394,696 shares of Ocular TherapeutixSEC Form 413 April 2026Common Stock · traded 9 April 2026 · filed 13 April 2026
- ▼ sold on the open market 20,056 shares of Ocular TherapeutixSEC Form 425 February 2026Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 20,056 shares of Ocular TherapeutixSEC Form 425 February 2026Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 124,882 shares of Ocular TherapeutixSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- ▼ sold on the open market 124,882 shares of Ocular TherapeutixSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- ▼ sold on the open market 19,530 shares of Ocular TherapeutixSEC Form 426 November 2025Common Stock · traded 24 November 2025 · filed 26 November 2025
- gave away 49,754 shares of Ocular TherapeutixSEC Form 426 November 2025Common Stock · traded 26 November 2025 · filed 26 November 2025
- gave away 49,754 shares of Ocular TherapeutixSEC Form 426 November 2025Common Stock · traded 26 November 2025 · filed 26 November 2025
- gave away 49,754 shares of Ocular TherapeutixSEC Form 411 September 2025Common Stock · traded 9 September 2025 · filed 11 September 2025
- gave away 49,754 shares of Ocular TherapeutixSEC Form 411 September 2025Common Stock · traded 9 September 2025 · filed 11 September 2025
- ▼ sold on the open market 21,494 shares of Ocular TherapeutixSEC Form 427 August 2025Common Stock · traded 25 August 2025 · filed 27 August 2025
- gave away 200,332 shares of Ocular TherapeutixSEC Form 413 August 2025Common Stock · traded 28 April 2025 · filed 13 August 2025
- gave away 50,029 shares of Ocular TherapeutixSEC Form 413 August 2025Common Stock · traded 12 June 2025 · filed 13 August 2025
- gave away 250,361 shares of Ocular TherapeutixSEC Form 413 August 2025Common Stock · traded 11 August 2025 · filed 13 August 2025
- was granted 2,750,000 shares of Ocular Therapeutix (a derivative holding)SEC Form 413 June 2025Performance Stock Option (Right to Buy) · traded 11 June 2025 · filed 13 June 2025
- ▼ sold on the open market 21,219 shares of Ocular TherapeutixSEC Form 427 May 2025Common Stock · traded 23 May 2025 · filed 27 May 2025
- ▼ sold on the open market 21,475 shares of Ocular TherapeutixSEC Form 426 February 2025Common Stock · traded 24 February 2025 · filed 26 February 2025
- was granted 1,250,000 shares of Ocular TherapeutixSEC Form 413 February 2025Common Stock · traded 11 February 2025 · filed 13 February 2025
- was granted 1,500,000 shares of Ocular TherapeutixSEC Form 413 February 2025Common Stock · traded 11 February 2025 · filed 13 February 2025
- ▼ sold on the open market 20,680 shares of Ocular TherapeutixSEC Form 427 November 2024Common Stock · traded 25 November 2024 · filed 27 November 2024
- ▼ sold on the open market 20,880 shares of Ocular TherapeutixSEC Form 427 August 2024Common Stock · traded 23 August 2024 · filed 27 August 2024
- ▼ sold on the open market 21,626 shares of Ocular TherapeutixSEC Form 428 May 2024Common Stock · traded 23 May 2024 · filed 28 May 2024
- was granted 1,282,469 shares of Ocular Therapeutix (a derivative holding)SEC Form 426 February 2024Stock Option (Right to Buy) · traded 22 February 2024 · filed 26 February 2024
- was granted 854,979 shares of Ocular TherapeutixSEC Form 426 February 2024Common Stock · traded 22 February 2024 · filed 26 February 2024
- returned to the issuer 8,625 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Restricted Stock Units · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 50,000 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Restricted Stock Units · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 37,500 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Restricted Stock Units · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 70,000 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Restricted Stock Units · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 27,500 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Restricted Stock Units · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 300,000 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Stock Option (Right to Buy) · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 110,000 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Stock Option (Right to Buy) · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 35,000 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Stock Option (Right to Buy) · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 100,000 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Stock Option (Right to Buy) · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 140,000 shares of IVERIC bio (a derivative holding)SEC Form 413 July 2023Stock Option (Right to Buy) · traded 11 July 2023 · filed 13 July 2023
- returned to the issuer 203,035 shares of IVERIC bioSEC Form 413 July 2023Common Stock · traded 11 July 2023 · filed 13 July 2023
- exercised options over 4,312 shares of IVERIC bio (a derivative holding)SEC Form 411 May 2023Restricted Stock Units · traded 3 May 2023 · filed 11 May 2023
- exercised options over 4,312 shares of IVERIC bioSEC Form 411 May 2023Common Stock · traded 3 May 2023 · filed 11 May 2023
- exercised options over 50,000 shares of IVERIC bio (a derivative holding)SEC Form 44 April 2023Restricted Stock Units · traded 1 April 2023 · filed 4 April 2023
- exercised options over 50,000 shares of IVERIC bioSEC Form 44 April 2023Common Stock · traded 1 April 2023 · filed 4 April 2023
- exercised options over 12,500 shares of IVERIC bio (a derivative holding)SEC Form 44 January 2023Restricted Stock Units · traded 2 January 2023 · filed 4 January 2023
- exercised options over 12,500 shares of IVERIC bioSEC Form 44 January 2023Common Stock · traded 2 January 2023 · filed 4 January 2023
- was granted 140,000 shares of IVERIC bio (a derivative holding)SEC Form 422 December 2022Stock Option (right to buy) · traded 20 December 2022 · filed 22 December 2022
- was granted 70,000 shares of IVERIC bio (a derivative holding)SEC Form 422 December 2022Restricted Stock Units · traded 20 December 2022 · filed 22 December 2022
- exercised options over 13,750 shares of IVERIC bio (a derivative holding)SEC Form 420 December 2022Restricted Stock Units · traded 18 December 2022 · filed 20 December 2022
- exercised options over 13,750 shares of IVERIC bioSEC Form 420 December 2022Common Stock · traded 18 December 2022 · filed 20 December 2022
- exercised options over 8,474 shares of IVERIC bio (a derivative holding)SEC Form 421 November 2022Stock Option (right to buy) · traded 17 November 2022 · filed 21 November 2022
- exercised options over 8,474 shares of IVERIC bioSEC Form 421 November 2022Common Stock · traded 17 November 2022 · filed 21 November 2022
- exercised options over 4,313 shares of IVERIC bio (a derivative holding)SEC Form 45 May 2022Restricted Stock Units · traded 3 May 2022 · filed 5 May 2022
- exercised options over 4,313 shares of IVERIC bioSEC Form 45 May 2022Common Stock · traded 3 May 2022 · filed 5 May 2022
- exercised options over 50,000 shares of IVERIC bio (a derivative holding)SEC Form 45 April 2022Restricted Stock Units · traded 1 April 2022 · filed 5 April 2022
- exercised options over 50,000 shares of IVERIC bioSEC Form 45 April 2022Common Stock · traded 1 April 2022 · filed 5 April 2022
- exercised options over 13,750 shares of IVERIC bio (a derivative holding)SEC Form 421 December 2021Restricted Stock Units · traded 18 December 2021 · filed 21 December 2021
- exercised options over 13,750 shares of IVERIC bioSEC Form 421 December 2021Common Stock · traded 18 December 2021 · filed 21 December 2021
- was granted 100,000 shares of IVERIC bio (a derivative holding)SEC Form 420 December 2021Stock Option (Right to Buy) · traded 16 December 2021 · filed 20 December 2021
- was granted 50,000 shares of IVERIC bio (a derivative holding)SEC Form 420 December 2021Restricted Stock Units · traded 16 December 2021 · filed 20 December 2021
- exercised options over 4,237 shares of IVERIC bio (a derivative holding)SEC Form 415 November 2021Stock Option (Right to Buy) · traded 11 November 2021 · filed 15 November 2021
- exercised options over 4,237 shares of IVERIC bioSEC Form 415 November 2021Common Stock · traded 11 November 2021 · filed 15 November 2021
- was granted 6,331 shares of Aerpio PharmaceuticalsSEC Form 42 July 2021Common Stock · traded 30 June 2021 · filed 2 July 2021
- was granted 35,000 shares of IVERIC bio (a derivative holding)SEC Form 44 May 2021Stock Option (Right to Buy) · traded 3 May 2021 · filed 4 May 2021
- was granted 17,250 shares of IVERIC bio (a derivative holding)SEC Form 44 May 2021Restricted Stock Units · traded 3 May 2021 · filed 4 May 2021
- exercised options over 50,000 shares of IVERIC bioSEC Form 45 April 2021Common Stock · traded 1 April 2021 · filed 5 April 2021
- exercised options over 20,000 shares of IVERIC bioSEC Form 45 April 2021Common Stock · traded 1 April 2021 · filed 5 April 2021
- ▼ sold on the open market 28,301 shares of IVERIC bioSEC Form 45 April 2021Common Stock · traded 5 April 2021 · filed 5 April 2021
- exercised options over 50,000 shares of IVERIC bio (a derivative holding)SEC Form 45 April 2021Restricted Stock Units · traded 1 April 2021 · filed 5 April 2021
- exercised options over 20,000 shares of IVERIC bio (a derivative holding)SEC Form 45 April 2021Restricted Stock Units · traded 1 April 2021 · filed 5 April 2021
- was granted 6,237 shares of Aerpio PharmaceuticalsSEC Form 42 April 2021Common Stock · traded 31 March 2021 · filed 2 April 2021
- was granted 17,857 shares of Aerpio Pharmaceuticals (a derivative holding)SEC Form 43 February 2021Stock Option (Right to Buy) · traded 1 February 2021 · filed 3 February 2021
- was granted 110,000 shares of IVERIC bio (a derivative holding)SEC Form 422 December 2020Stock Option (Right to Buy) · traded 18 December 2020 · filed 22 December 2020
- was granted 55,000 shares of IVERIC bio (a derivative holding)SEC Form 422 December 2020Restricted Stock Units · traded 18 December 2020 · filed 22 December 2020
- was granted 52,144 shares of Aerpio Pharmaceuticals (a derivative holding)SEC Form 426 June 2020Stock Option (Right to Buy) · traded 24 June 2020 · filed 26 June 2020
- was granted 21,400 shares of Aerpio Pharmaceuticals (a derivative holding)SEC Form 419 June 2019Stock Option (Right to Buy) · traded 18 June 2019 · filed 19 June 2019
- was granted 2,500 shares of Aerpio Pharmaceuticals (a derivative holding)SEC Form 416 November 2018Stock Option (Right to Buy) · traded 26 October 2018 · filed 16 November 2018
- was granted 21,400 shares of Aerpio Pharmaceuticals (a derivative holding)SEC Form 422 June 2018Stock Option (Right to Buy) · traded 20 June 2018 · filed 22 June 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.